Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces the recipients of its annual research awards program for porcine circovirus-associated disease (PCVAD).
Each of three researchers receives $75,000 for research studies aimed at improving the industry’s understanding and management of the devastating disease.
Recognized at the Leman Swine Conference in St. Paul, MN, were:
Brad Leuwerke, DVM, Swine Vet Center, St. Peter, MN, for a study to determine the influence of maternal antibodies to circovirus type 2 (PCV2) on interference of circovirus vaccination efficacy in young pigs.
Tanja Opriessnig, DVM, Iowa State University, for a study to determine the prevalence of PCV2 viremia (viral infection of the blood) and persistent infection in conventional piglets at birth.
Tanja Opriessnig, DVM, Iowa State University, for a study to evaluate the influence of porcine reproductive and respiratory syndrome (PRRS) virus viremia on circovirus vaccine efficacy in conventional growing pigs.